Basal cell carcinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.


 
==Overview
==Overview==
In 2014, the average annual incidence of basal cell carcinoma in the United States was 878 cases per 100,000 individuals. The incidence increases with age and is higher in men. BCC is the most common in the Caucasian race.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 12: Line 12:
===Age===
===Age===
The incidence of BCC increases with age - persons aged 55 to 75 years have about a 100-fold higher incidence of BCC than those younger than 20 years<ref>Scotto J, Fears TR, Fraumeni JF Jr, et al. Incidence of nonmelanoma skin cancer in the United States in collaboration with Fred Hutchinson Cancer Research Center. NIH publication No. 83-2433, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1983:xv. p.11</ref>
The incidence of BCC increases with age - persons aged 55 to 75 years have about a 100-fold higher incidence of BCC than those younger than 20 years<ref>Scotto J, Fears TR, Fraumeni JF Jr, et al. Incidence of nonmelanoma skin cancer in the United States in collaboration with Fred Hutchinson Cancer Research Center. NIH publication No. 83-2433, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1983:xv. p.11</ref>


===Gender===
===Gender===

Revision as of 18:25, 27 July 2015

Basal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Basal Cell Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Basal cell carcinoma epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Basal cell carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Basal cell carcinoma epidemiology and demographics

CDC on Basal cell carcinoma epidemiology and demographics

Basal cell carcinoma epidemiology and demographics in the news

Blogs on Basal cell carcinoma epidemiology and demographics

Directions to Hospitals Treating Basal cell carcinoma

Risk calculators and risk factors for Basal cell carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

==Overview In 2014, the average annual incidence of basal cell carcinoma in the United States was 878 cases per 100,000 individuals. The incidence increases with age and is higher in men. BCC is the most common in the Caucasian race.

Epidemiology and Demographics

Incidence

  • In 2014, the average annual incidence of BCC in the United States was 878 cases per 100,000 individuals[1]

Age

The incidence of BCC increases with age - persons aged 55 to 75 years have about a 100-fold higher incidence of BCC than those younger than 20 years[2]

Gender

  • The incidence of BCC is 30% higher in men than in women (particularly with the superficial type)[3][4][5]

Race

  • Basal cell carcinoma is common in the Caucasian race, and very uncommon in the African American race and other darker-skinned populations[6]

Developed Countries

Developing Countries

References

  1. Mohan SV, Chang AL (2014). "Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations". Curr Dermatol Rep. 3: 40–45. doi:10.1007/s13671-014-0069-y. PMC 3931971. PMID 24587976.
  2. Scotto J, Fears TR, Fraumeni JF Jr, et al. Incidence of nonmelanoma skin cancer in the United States in collaboration with Fred Hutchinson Cancer Research Center. NIH publication No. 83-2433, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1983:xv. p.11
  3. Hannuksela-Svahn A, Pukkala E, Karvonen J (1999). "Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995". Arch Dermatol. 135 (7): 781–6. PMID 10411152.
  4. Green A, Battistutta D, Hart V, Leslie D, Weedon D (1996). "Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group". Am J Epidemiol. 144 (11): 1034–40. PMID 8942434.
  5. Chuang TY, Popescu A, Su WP, Chute CG (1990). "Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota". J Am Acad Dermatol. 22 (3): 413–7. PMID 2312827.
  6. American Cancer Society. Cancer facts and figures 2000. www.cancer.org.2001 (Accessed on March 08, 2005)


Template:WikiDoc Sources